Abstract
Nocardiosis is a life-threatening opportunistic infection in immunocompromised patients. Herein, we present successful adjunctive use of liposomal nebulized amikacin and tedizolid in a recipient of allogeneic hematopoietic stem cell transplantation infected with Nocardia nova complex who presented multiple complications to conventional therapeutic options.
Keywords:
Allogeneic hematopoietic stem cell transplantation; Liposomal nebulized amikacin; Nocardiosis; Tedizolid.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
MeSH terms
-
Amikacin / pharmacology*
-
Anti-Bacterial Agents / therapeutic use*
-
Hematopoietic Stem Cell Transplantation / adverse effects*
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Liposomes / administration & dosage*
-
Liposomes / chemistry
-
Liposomes / therapeutic use
-
Male
-
Middle Aged
-
Nebulizers and Vaporizers
-
Nocardia / drug effects*
-
Nocardia Infections / diagnosis
-
Nocardia Infections / drug therapy*
-
Oxazolidinones / pharmacology*
-
Tetrazoles / pharmacology*
-
Time Factors
Substances
-
Anti-Bacterial Agents
-
Immunosuppressive Agents
-
Liposomes
-
Oxazolidinones
-
Tetrazoles
-
Amikacin
-
tedizolid